Injection Pen Market Set to Surge, Valued at USD 40.6 Billion in 2023, Projected to Reach USD 73.8 Billion by 2032
The global injection pen market is expanding at a fast rate with the growing prevalence of chronic diseases, and increasing demand for convenient self-administration options. This trend is a move ...
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
AZ Central12d
As insulin shortages persist, what diabetes patients can do
Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter vials. The company said new regulations had led to a brief delay in manufacturing ...
Milwaukee Journal Sentinel12d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi. Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk ...
New Atlas19d
‘Insulin with a switch’ will help diabetics avoid dangerous hypos
“Notably, glucose values vary over a narrow range (from approximately 2 to 20-30 mM [36 mg/dL to 360-540 mg/dL] in people with diabetes), so a rather steep change in insulin bioactivity must be ...